Metabolic syndrome and subclinical atherosclerosis in patients infected with HIV. - Wikidata - awgldk - TriplyDB

Metabolic syndrome and subclinical atherosclerosis in patients infected with HIV.

Metabolic syndrome and subclinical atherosclerosis in patients infected with HIV.

http://www.wikidata.org/entity/Q37350467

about

Pro-Inflammatory Markers in Relation to Cardiovascular Disease in HIV Infection. A Systematic Review Metabolic syndrome, diabetes, and cardiovascular risk in HIV Arterial disease in patients with human immunodeficiency virus infection: what has imaging taught us?Risk stratification and prognosis of human immunodeficiency virus-infected patients with known or suspected coronary artery disease referred for stress echocardiography.Carotid intima media thickness is associated with body fat abnormalities in HIV-infected patients Role of metabolic syndrome components in human immunodeficiency virus-associated stroke.Impact of Lipodystrophy on the prevalence and components of metabolic syndrome in HIV-infected patients.Stimulation of the liver X receptor pathway inhibits HIV-1 replication via induction of ATP-binding cassette transporter A1 Impact of randomized antiretroviral therapy initiation on glucose metabolism Increased coronary artery calcium score and noncalcified plaque among HIV-infected men: relationship to metabolic syndrome and cardiac risk parameters.Clinically significant incidental findings among human immunodeficiency virus-infected men during computed tomography for determination of coronary artery calcium.Effect of Nadir CD4+ T cell count on clinical measures of periodontal disease in HIV+ adults before and during immune reconstitution on HAART.Fatty liver disease is associated with underlying cardiovascular disease in HIV-infected persons(*).A cross-sectional assessment of metabolic syndrome in HIV-infected people of low socio-economic status receiving antiretroviral therapy Hypertriglyceridemia, Metabolic Syndrome, and Cardiovascular Disease in HIV-Infected Patients: Effects of Antiretroviral Therapy and Adipose Tissue Distribution.A prospective cohort study of periodontal disease measures and cardiovascular disease markers in HIV-infected adults.Food security and nutrition in the Russian Federation - a health policy analysis Increased pericardial fat accumulation is associated with increased intramyocardial lipid content and duration of highly active antiretroviral therapy exposure in patients infected with human immunodeficiency virus: a 3T cardiovascular magnetic reso Comparison of Insulin Resistance to Coronary Atherosclerosis in Human Immunodeficiency Virus Infected and Uninfected Men (from the Multicenter AIDS Cohort Study).Metabolic syndrome predicts all-cause mortality in persons with human immunodeficiency virus Comparison of ischemic stroke incidence in HIV-infected and non-HIV-infected patients in a US health care system.Effects of lifestyle modification and metformin on atherosclerotic indices among HIV-infected patients with the metabolic syndrome Ultrasound measurements of carotid intima-media thickness and plaque in HIV-infected patients on the Mediterranean diet.Dietary patterns and health and nutrition outcomes in men living with HIV infection.Endothelial activation markers are linked to HIV status and are independent of antiretroviral therapy and lipoatrophy.Relationship between inflammatory markers, endothelial activation markers, and carotid intima-media thickness in HIV-infected patients receiving antiretroviral therapy.Noninvasive assessment of HIV-related coronary artery disease.Hypertension Is a Key Feature of the Metabolic Syndrome in Subjects Aging with HIV Prevalence of metabolic syndrome in HIV-infected patients naive to antiretroviral therapy or receiving a first-line treatment.Liver X receptor agonist inhibits HIV-1 replication and prevents HIV-induced reduction of plasma HDL in humanized mouse model of HIV infection.Atherosclerosis is associated with a higher risk of hepatic steatosis in HIV-infected patients.Prevalence and risk factors for osteopenia/osteoporosis in an HIV-infected male population.Visceral adipose tissue and carotid intima-media thickness in HIV-infected patients undergoing cART: a prospective cohort study.HIV quality of care assessment at an academic hospital: outcomes and lessons learned.

P2860

Q26774828-F6760003-8F98-456B-A47B-47B8525DB2C5 Q26853470-F0C53B6A-F2B5-4AC4-B330-1A6E6055DB43 Q27026486-B41853DE-5E2A-49DB-9CBB-D08D7792E0B7 Q30457521-BB4DBF8F-C0AF-4FE4-88A0-04AD3967E6CC Q33864945-3A91A676-FCBB-4D8C-A65A-A753A28B78EF Q33938800-7D1CF976-8415-4F95-9A27-02659F2DE9C2 Q34024617-EB07F3B5-BD66-433F-92E3-919E302629D9 Q34051644-91358D69-B88B-485A-B81F-EA5AF43DC844 Q34205448-5F762D25-88E3-4421-A05B-B3D116FDB73F Q34283290-A1E0F95A-BD9F-478E-860C-E2C0CB03EBE7 Q34789165-1C56846A-E798-40DE-8DA6-1A18E38AFF67 Q35023018-71FEF204-84FD-4D5F-BE5E-64C482D69F3B Q35103486-C8A996F0-4A55-41BB-9CA1-11574907AEF7 Q35166766-7F4EEB51-AF2F-4053-94B2-E9AC4A7403D8 Q35176441-A5459E89-4433-40D2-BA5E-00918DA2B77A Q35508301-7DB0DB99-FB9E-43C0-A850-200F20CB94C2 Q35782530-E4C706AD-D706-4C27-B0E3-D22222BA1DEB Q35828384-005DFBA7-4ACE-4513-9D6C-05E77FB3D8B0 Q36642595-BD6CFB17-76CD-4258-BF1C-85AE5811EA28 Q36836525-E2F5851A-54A8-4336-84CD-B2DBF9403F38 Q36894824-41DDE4B5-0892-4254-BD48-C48A7DDC4E2E Q36909684-677E618A-E31F-4328-8098-640A04EBB643 Q37147740-AE4B02BF-2301-4FA6-B24E-7693B7A7EB43 Q37328361-9BD922D4-3996-4176-A379-541F2A4241BA Q37423408-56C0BF73-FFC4-4A9C-BBF2-ED42C43EC21A Q37492492-F9265F3B-D870-4776-80B2-91FF8B18E93D Q37846118-C60F5C32-26F9-400A-86A6-EBFAC468B3D2 Q38821848-F011D1B6-AD66-4758-905D-642C9B3422C8 Q38831718-631FFCE3-E657-447D-B0B4-2999D4CE3282 Q42602737-C158E96E-8126-4AD0-903E-F9DC804446F5 Q43163566-9B8E14FB-D560-4534-8DE7-1FDD259F89BB Q46878365-27574C19-F93D-467C-97F2-BD240E59845E Q48043453-C62B52C6-8691-48D9-B7AC-947591A2AA70 Q53665342-EFC1D5F2-C07A-463C-9227-9DFE1EAC28B4

P2860

Metabolic syndrome and subclinical atherosclerosis in patients infected with HIV.

http://www.wikidata.org/entity/Q37350467

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 05 April 2007

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Metabolic syndrome and subclinical atherosclerosis in patients infected with HIV.

@en

Metabolic syndrome and subclinical atherosclerosis in patients infected with HIV.

@nl

type

label

Metabolic syndrome and subclinical atherosclerosis in patients infected with HIV.

@en

Metabolic syndrome and subclinical atherosclerosis in patients infected with HIV.

@nl

prefLabel

Metabolic syndrome and subclinical atherosclerosis in patients infected with HIV.

@en

Metabolic syndrome and subclinical atherosclerosis in patients infected with HIV.

@nl

P1433

Q37350467-57AAA4AE-088F-4692-AF81-EB711D0D8CE5

P1476

Q37350467-9372DA77-6570-4A23-B38C-6A6CC9C7A9AA

P2093

Q37350467-123E7DDE-6D33-4F0F-9EEE-8D4786E8B10C

Q37350467-190D38AC-4A57-4D23-A121-40C5F429DE07

Q37350467-255DD517-FDCE-4F91-8422-6E19AECFA832

Q37350467-3F5DB4F8-6163-41C5-9210-13621CCF0400

Q37350467-634E1DA6-766D-4C63-8B60-717CFD7D7CC9

Q37350467-F5B0502C-31EC-4CD9-A597-BDDA20045C8D

P2860

Q37350467-0B316A28-5E0F-4D35-AD7B-16BB5284FBC3

Q37350467-0C622CCD-2020-4CAD-81C4-2653287D972C

Q37350467-0D7C6994-433A-4BF5-A2C8-28E325872545

Q37350467-10D62D82-5D7F-4584-B02B-C16EA63F2DB3

Q37350467-15974129-3A30-4FA9-B650-9A23EDED46F8

Q37350467-16FCA137-7C3E-441C-89F5-7573DEC96BA5

Q37350467-2411AF4B-B05F-4693-BC30-11929792B6EB

Q37350467-282E8A50-EC32-4A8D-8258-03E04CF17CAF

Q37350467-29C98CEF-3BAC-4784-94C3-FED11446391D

Q37350467-2CE272B7-DB51-404B-9885-096C8A74C3BA

P304

Q37350467-6106B645-0874-4D30-AE51-3D93C720B38B

P31

Q37350467-4F5233C3-0B7E-41B0-A373-FCB89E968C63

P356

Q37350467-B79E4CA9-3DB4-4490-90B6-F52F88C742BF

P407

Q37350467-274EBBC2-2C5F-4BAB-ADC9-36CA001BB027

P433

Q37350467-399796D2-36D3-4F51-B040-67F284CE19ED

P478

Q37350467-575B8063-5CC0-411F-AEA9-2C064D1392F0

P577

Q37350467-FAFEBEDA-2F1D-416E-A242-F6DF3E39AD35

P5875

Q37350467-E0F2FF7B-1541-44A4-8448-97FD046C837E

P698

Q37350467-2653E381-5A85-4026-883B-861F57613884

P921

Q37350467-A6DEC917-9089-4F1D-B751-7DFACEBB50AF

Q37350467-B5A7B986-20C2-41B7-9727-C4CEE83F20DD

Q37350467-B71502EC-9000-4684-B8CB-4CBF5A1ECEF2

Q37350467-BA669D36-733B-4E7B-8765-C835BBB3EDD8

P932

Q37350467-BF81E17E-5DD8-4C1D-B7B4-6B7EC146A60B

P356

P1433

Clinical Infectious Diseases

P1476

Metabolic syndrome and subclinical atherosclerosis in patients infected with HIV.

@en

P2093

Alexandra Mangili

http://www.w3.org/2001/XMLSchema#string

Christine A Wanke

http://www.w3.org/2001/XMLSchema#string

Denise L Jacobson

http://www.w3.org/2001/XMLSchema#string

Joseph F Polak

http://www.w3.org/2001/XMLSchema#string

Jul Gerrior

http://www.w3.org/2001/XMLSchema#string

Sherwood L Gorbach

http://www.w3.org/2001/XMLSchema#string

P2860

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey

CD4+ count-guided interruption of antiretroviral treatment

Carotid atherosclerosis and coronary heart disease in the metabolic syndrome: prospective data from the Bruneck study.

Coronary artery calcium quantification with retrospectively gated helical CT: protocols and techniques.

Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition.

Pilot study of coronary atherosclerotic risk and plaque burden in HIV patients: 'a call for cardiovascular prevention'.

Intima-media thickness: a tool for atherosclerosis imaging and event prediction.

Evaluation and management of metabolic and coagulative disorders in HIV-infected patients receiving highly active antiretroviral therapy.

Carotid intimal medial thickness in human immunodeficiency virus-infected women: effects of protease inhibitor use, cardiac risk factors, and the metabolic syndrome.

P304

1368-1374

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1086/516616

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

44

http://www.w3.org/2001/XMLSchema#string

P577

2007-04-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6386174

http://www.w3.org/2001/XMLSchema#string

P698

17443477

http://www.w3.org/2001/XMLSchema#string

P921

atherosclerosis

metabolic syndrome

P932

2745593

http://www.w3.org/2001/XMLSchema#string